{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:45:24Z","timestamp":1791315924111,"version":"4.3.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["BFU2015-63800-R"],"award-info":[{"award-number":["BFU2015-63800-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-094011-B100"],"award-info":[{"award-number":["RTI2018-094011-B100"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI17\/00624"],"award-info":[{"award-number":["PI17\/00624"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI16\/00103"],"award-info":[{"award-number":["PI16\/00103"]}]},{"DOI":"10.13039\/501100002924","name":"FEDER,","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grifols"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T03:39:30Z","timestamp":1557373170000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection"],"prefix":"10.1016","volume":"168","author":[{"given":"Edurne","family":"Garcia-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Badia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pujantell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Castellv\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eudald","family":"Felip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Riveira-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Ballana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Est\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.05.003_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/QAD.0000000000000572","article-title":"Select host restriction factors are associated with HIV persistence during antiretroviral therapy","volume":"29","author":"Abdel-Mohsen","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2019.05.003_bib2","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.1074\/jbc.M113.472159","article-title":"Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels","volume":"288","author":"Amie","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.05.003_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00292-18","article-title":"SAMHD1 impairs HIV-1 gene expression and negatively modulates reactivation of viral latency in CD4(+) T cells","volume":"92","author":"Antonucci","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12985-016-0637-9","article-title":"Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412","volume":"13","author":"Ao","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.05.003_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkv363","article-title":"Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1","volume":"71","author":"Badia","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.03.019","article-title":"SAMHD1 is active in cycling cells permissive to HIV-1 infection","volume":"142","author":"Badia","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.antiviral.2019.05.003_bib7","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41467-018-05157-w","article-title":"CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir","volume":"9","author":"Badia","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.05.003_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2015.09.004","article-title":"The thioacetate-omega(gamma-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent","volume":"123","author":"Badia","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib9","doi-asserted-by":"crossref","first-page":"e1005829","DOI":"10.1371\/journal.ppat.1005829","article-title":"The G1\/S specific cyclin D2 is a regulator of HIV-1 restriction in non-proliferating cells","volume":"12","author":"Badia","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.003_bib10","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.05.003_bib11","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/AAC.03145-14","article-title":"SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors","volume":"58","author":"Ballana","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.tim.2015.08.002","article-title":"SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction","volume":"23","author":"Ballana","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib13","doi-asserted-by":"crossref","first-page":"e102684","DOI":"10.1371\/journal.pone.0102684","article-title":"Selective HDAC inhibition for the disruption of latent HIV-1 infection","volume":"9","author":"Barton","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.003_bib14","first-page":"2275","article-title":"Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity","volume":"18","author":"Begemann","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/v10110620","article-title":"Detailed characterization of early HIV-1 replication dynamics in primary human macrophages","volume":"10","author":"Bejarano","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.05.003_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcp.2016.02.002","article-title":"Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells","volume":"106","author":"Bermejo","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/infdis\/jis412","article-title":"Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy","volume":"206","author":"Blazkova","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","article-title":"The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic","volume":"85","author":"Broder","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI80565","article-title":"Molecular mechanisms of HIV latency","volume":"126","author":"Cary","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2019.05.003_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1172\/JCI44539","article-title":"CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21","volume":"121","author":"Chen","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2019.05.003_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nsmb.3328","article-title":"Position effects influence HIV latency reversal","volume":"24","author":"Chen","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.142.2.431","article-title":"Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone","volume":"142","author":"Clouse","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature21710","article-title":"CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses","volume":"543","author":"Descours","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.05.003_bib24","first-page":"17","article-title":"PKC412--a protein kinase inhibitor with a broad therapeutic potential","volume":"15","author":"Fabbro","year":"2000","journal-title":"Anti Cancer Drug Des."},{"key":"10.1016\/j.antiviral.2019.05.003_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/srep38162","article-title":"Immune activation influences SAMHD1 expression and vpx-mediated SAMHD1 degradation during chronic HIV-1 infection","volume":"6","author":"Fu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.05.003_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01368-17","article-title":"Evaluation of the innate immune modulator acitretin as a strategy to clear the HIV reservoir","volume":"61","author":"Garcia-Vidal","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/aid.2014.0199","article-title":"Targeting NF-\u03baB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency","volume":"31","author":"Guochun","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.antiviral.2019.05.003_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.05.003_bib29","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2019.05.003_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12929-015-0150-2","article-title":"Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family","volume":"22","author":"Kawai","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2019.05.003_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201ckill\u201d into \u201cshock and kill\u201d: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.05.003_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.05.003_bib33","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2017-05-782292","article-title":"Midostaurin approved for FLT3-mutated AML","volume":"129","author":"Levis","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2019.05.003_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nm.4124","article-title":"Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation","volume":"22","author":"Li","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.05.003_bib35","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1128\/JVI.74.18.8307-8315.2000","article-title":"Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells","volume":"74","author":"Mangeot","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib36","doi-asserted-by":"crossref","first-page":"604","DOI":"10.15252\/embj.201696025","article-title":"A G1\u2010like state allows HIV\u20101 to bypass SAMHD1 restriction in macrophages","volume":"36","author":"Mlcochova","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2019.05.003_bib37","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/QAD.0000000000000399","article-title":"Palbociclib, a selective inhibitor of cyclin-dependent kinase 4\/6, blocks HIV-1 reverse transcription through the control of sterile alpha motif and HD domain-containing protein-1 (SAMHD1) activity","volume":"28","author":"Pauls","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2019.05.003_bib38","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.4049\/jimmunol.1400873","article-title":"Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells","volume":"193","author":"Pauls","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib39","doi-asserted-by":"crossref","first-page":"E1322","DOI":"10.1073\/pnas.1322059111","article-title":"p21 regulates the HIV-1 restriction factor SAMHD1","volume":"111","author":"Pauls","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.003_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2016.08.004","article-title":"Long-term HIV-1 infection induces an antiviral state in primary macrophages","volume":"133","author":"Pujantell","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2018.05.012","article-title":"ADAR1 affects HCV infection by modulating innate immune response","volume":"156","author":"Pujantell","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib42","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.1038\/s41598-017-13580-0","article-title":"RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages","volume":"7","author":"Pujantell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.05.003_bib43","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/jac\/dku276","article-title":"Increased expression of SAMHD1 in a subset of HIV-1 elite controllers","volume":"69","author":"Riveira-Munoz","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib44","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1128\/AAC.01077-15","article-title":"Ex vivo bioactivity and HIV-1 latency reversal by ingenol dibenzoate and panobinostat in resting CD4(+) T cells from aviremic patients","volume":"59","author":"Spivak","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01361-18","article-title":"Synthetic ingenols maximize protein kinase C-induced HIV-1 latency reversal","volume":"62","author":"Spivak","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.05.003_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2018.10.017","article-title":"Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors","volume":"160","author":"Surdo","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2018.02.017","article-title":"Inhibition of NF-\u03baB-dependent HIV-1 replication by the marine natural product bengamide A","volume":"152","author":"Tietjen","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01324-17","article-title":"p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of deoxynucleoside triphosphate biosynthesis and regulation of SAMHD1 antiviral activity","volume":"91","author":"Valle-Casuso","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01744-18","article-title":"Inhibitors of signaling pathways that block reversal of HIV-1 latency","volume":"63","author":"Vargas","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.05.003_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2016.11.014","article-title":"Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation","volume":"139","author":"Vemula","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.003_bib52","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1128\/JVI.02074-06","article-title":"Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1","volume":"81","author":"Williams","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.003_bib53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jac\/dkr496","article-title":"Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation","volume":"67","author":"Xing","year":"2012","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T11:09:25Z","timestamp":1694862565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219300610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":53,"alternative-id":["S0166354219300610"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}